Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04213287
Other study ID # 70/13
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 23, 2019
Est. completion date March 15, 2020

Study information

Verified date December 2019
Source Ankara Diskapi Training and Research Hospital
Contact ilkay MD Baran akkus, MD
Phone 0905323852642
Email ilkayb@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A comparison of two pain control methods - the combination of Adductor Canal Block (ACB)/Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (IPACK) versus the Periarticular Injection (PAI)/ Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (IPACK) - in patients undergoing total knee arthroplasty. dexketoprofen and paracetamol will be added to both groups and multimodal analgesia will be applied. Primary outcome is NRS pain scores with ambulation on postoperative day one (24 hours post-block administration).


Description:

Postoperative pain after total knee arthroplasty is serious and difficult to management. Multimodal analgesia recommended for the pain management. For these reasons, we planned a study involving two multimodal analgesia regimens. Patients who will undergo total knee arthroplasty will receive preemptive oral analgesic (dexketofrofen) 1 hour before the operation. Surgery will be initiated after spinal anesthesia is applied to the patients. Two pain control methods - the combination of Adductor Canal Block (ACB)/Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (IPACK) versus the Periarticular Injection (PAI)/ IPACK- will be applied at the end of the surgery. dexketoprofenand paracetamol will be added to both groups and multimodal analgesia will be applied. Primary outcome is NRS pain scores with ambulation on postoperative day one (24 hours post-block administration).


Recruitment information / eligibility

Status Recruiting
Enrollment 70
Est. completion date March 15, 2020
Est. primary completion date March 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Patients with osteoarthritis scheduled for a primary either partial or total knee arthroplasty with a participating surgeon

- Age 18 to 80 years

- Planned use of regional anesthesia

- Ability to follow study protocol

- Patients of participating surgeons

Exclusion Criteria:

- Hepatic or renal insufficiency

- Younger than 18 years old and older than 80

- Patients undergoing general anesthesia

- Allergy or intolerance to one of the study medications

- BMI > 40

- Diabetes

- ASA of IV

- Chronic gabapentin/pregabalin use (regular use for longer than 3 months)

- Chronic opioid use (taking opioids for longer than 3 months, or daily oral morphine equivalent of >5mg/day for one month)

Study Design


Intervention

Drug:
Dexketoprofen Trometamol
Drug: Dexketoprofen Trometamol oral tablet
Other:
spinal anesthesia
Drug: heavy bupivacaine 2,5 ml 0,5%
IPACK
Drug: bupivacaine 20 ml 0,025%
PAI
Drug: bupivacaine 30 ml 0,025%
Adductor canal block
Drug: bupivacaine 20 ml 0,025%

Locations

Country Name City State
Turkey Diskapi Yildirim Beyazit Training Research Hospital Ankara Altindag

Sponsors (1)

Lead Sponsor Collaborator
Ankara Diskapi Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary NRS Pain Scores NRS Pain scores with ambulation 24 hours post block administration.All patients' postoperative pain numerical rating scale (NRS-numeric rating scale; 0 = absence of pain, 10 = unbearable pain) will be recorded in both groups. 24 hours post block administration
Secondary NRS at Rest and with movement NRS at rest and with movement at different intervals. All patients' postoperative pain numerical rating scale (NRS-numeric rating scale; 0 = absence of pain, 10 = unbearable pain) will be recorded in both groups. 24 hours on Post-Operative Day 1
Secondary Patient Satisfaction with Pain Control using the likert scale Satisfaction with Pain control at different intervals. 1-5 (according to patient satisfaction) Post-Operative 24 hours